Making Physician Referrals and Orders for Outpatient Services Easy – Why EHR Revenue Cycle Modules Aren’t Enough for Hospital Labs (Part 6)

As the sixth installment of this multi-part blog series, we address the needs of ordering or referring physicians to support them using your health system’s outpatient services. While the patient is always the primary customer, for hospital outpatient services such as ambulatory and outreach laboratory, as your outpatient and outreach programs expand further into the surrounding communities...

Read


XIFIN LIS Keeps Laboratories Nimble: Responding Quickly to Fluctuations in COVID-19 Testing Demand and Turnaround Times

Early in the COVID-19 pandemic, laboratories were focused on the capabilities needed to get them ramped up quickly to handle COVID-19 testing. As 2020 wore on, labs were challenged to keep up with significant fluctuations in COVID testing volume, as well as ongoing shortages in test supplies.In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced that starting January 1...

Read


Q&A Explores COVID's Impact on Lab Industry Testing Volumes and Dynamics

In a recent teleconference among XIFIN and UBS executives, XIFIN’s Chairman and CEO Lâle White and Chief Operating Officer Kyle Fetter discussed COVID-19's impact on lab industry testing volumes and dynamics.The one-hour conference revealed: Hospital volumes have come back stronger than any other sector Molecular volumes are doing well Genetic testing is continuing to increase with more...

Read


XIFIN Innovation Drives Growth in Four Critical Business Areas During COVID-19

Despite COVID-19's industry-altering effects on diagnostic labs and healthcare in general, XIFIN innovation in 2020 drove growth in four critical business areas: digital and genomic health, remote patient monitoring and medical device, healthcare informatics oncology, and traditional laboratory markets.XIFIN also generated notable client results and provided unique insights into lab testing...

Read


UHC Announces Designated Diagnostic Provider Requirements for Coverage

On February 24, 2021, XIFIN learned that UHC has delayed the application deadline from February 28, 2021 to March 10, 2021. The go-live date of July 1, 2021 is still in place. Additional requests to confirm how places of service 81, 11, 19, 22 are impacted has been requested from UHC. XIFIN will provide additional updates as they are received. UHC recently announced plans to implement the...

Read


Achieving Success with Next-Generation Sequencing: AI-driven Scale Plus a Strong Reimbursement Strategy

XIFIN, Inc. and Fabric Genomics recently collaborated on a webinar designed for laboratories launching or planning to launch Next-Generation Sequencing (NGS) tests. The two primary topics of the webinar are: The use of artificial intelligence (AI) to drive scale with panel testing, including practical considerations for implementing NGS testing and selecting the right panels, and automating...

Read


XIFIN Advanced Analytics Allows you to Build Custom Analytics: BI Expert

XIFIN Business Intelligence and Advanced Analytics provide the revenue cycle management (RCM) operational performance metrics and test-level data exploration diagnostic executives require to thrive in today’s competitive healthcare marketplace. In response to diagnostic leader’s need for accurate visualizations of operational performance, XIFIN created a suite of four Advanced Analytics solutions...

Read


XIFIN Advanced Analytics Help Diagnostic Financial, and Billing Leaders More Easily Explore Complex RCM Data: XIFIN BI Enterprise

RCM data is complex and by its very nature, changes through the claim lifecycle, which can make analysis challenging. That is why XIFIN RPM now offers advanced analytics and visualization options, in addition to its powerful business intelligence (BI) and reporting capabilities.Executive Advanced Analytics: Question and Answer Storyboard FormatXIFIN currently offers four advanced analytics...

Read